LONGEVA.
··

BPC-157 + TB-500 Blend

BPC-157 / TB-500 (Thymosin β4 fragment)

Purity>99.99%

The batch you'll receive

Batch: B-2026-BPC157-TB500-20-001

Lab: Janoshik

Purity: >99.99%

Test date: 28.07.2026

View this batch's certificate of analysis

Verify batch B-2026-BPC157-TB500-20-001 authenticity

Share
TelegramWhatsAppViber
For research use only
This product is sold as a reagent for laboratory research and is not intended for administration to humans or animals.
Delivery
International delivery: 7–21 days depending on the country. We confirm the cost after checkout. Kyiv delivery →
Payment
Cryptocurrency (USDT, BTC, ETH) or a Visa / Mastercard card (3-D Secure). Learn more →
Quality guarantee
Every batch is independently lab-tested. For research use only.

About

BPC-157 + TB-500 pairs two of the leading research peptides in tissue-repair science, combined in a single vial.

BPC-157 is a stable pentadecapeptide (15 amino acids) derived from a gastric protective protein, studied for angiogenesis and fibroblast migration. TB-500 is a synthetic actin-binding fragment of thymosin β4, studied for cell migration and extracellular-matrix remodelling. The mechanisms are distinct and are described in the literature as complementary, which is why the pair is commonly run together.

Supplied as a lyophilized powder; every batch is assayed by HPLC.

Specifications

Active substanceBPC-157 10 mg + TB-500 10 mg
Purity>99.99%
Formlyophilized powder

Dosing

Reference data — not a recommendation
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.

There is no verified published human regimen for the BPC-157 + TB-500 combination.

Full dosing guideTitration schedule · reference

Certificates of analysis

Search all BPC-157 / TB-500 (Thymosin β4 fragment) batches in the certificate of analysis archive

Related products